Filana Therapeutics, Inc. Shareholders' Equity
Filana Therapeutics, Inc. (FLNA) had Shareholders' Equity of $68.14 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-07
- 2026-03-31: Stockholders' Equity Attributable to Parent $68.14M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $74.40M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $81.57M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $87.97M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-03-31 | $68.14M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $74.40M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $81.57M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $87.97M 10-Q · filed 2025-11-12 |
| 2025-03-31 | $127.62M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $145.70M 10-Q · filed 2026-05-07 |
| 2024-09-30 | $166.64M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $188.97M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $78.60M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $137.47M 10-K · filed 2026-03-12 |
| 2023-09-30 | $155.12M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $179.35M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $204.00M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $227.54M 10-K · filed 2026-03-12 |
| 2022-09-30 | $198.72M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $218.37M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $237.09M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $253.91M 10-K · filed 2025-03-03 |
| 2021-09-30 | $267.56M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $276.48M 10-Q · filed 2022-11-07 |
| 2021-03-31 | $281.19M 10-Q · filed 2022-11-07 |
| 2020-12-31 | $92.20M 10-K · filed 2024-02-28 |
| 2020-09-30 | $23.97M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $24.18M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $24.83M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $22.10M 10-K · filed 2023-02-28 |
| 2019-09-30 | $17.45M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $17.82M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $18.55M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $19.63M 10-K · filed 2021-03-23 |
| 2018-09-30 | $19.97M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $8.55M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $10.30M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $9.70M 10-K · filed 2020-03-26 |
| 2017-09-30 | $11.37M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $13.27M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $16.72M 10-Q · filed 2017-04-26 |
| 2016-12-31 | $18.64M 10-K · filed 2019-03-29 |
| 2016-09-30 | $20.32M 10-Q · filed 2016-10-26 |
| 2016-06-30 | $22.99M 10-Q · filed 2016-07-19 |
| 2016-03-31 | $25.28M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $29.37M 10-K · filed 2018-02-06 |
| 2015-09-30 | $33.07M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $35.94M 10-Q · filed 2015-07-23 |
| 2015-03-31 | $38.44M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $40.06M 10-K · filed 2017-03-07 |
| 2014-09-30 | $41.21M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $43.65M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $45.70M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $48.30M 10-K · filed 2017-03-07 |
| 2013-09-30 | $14.25M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $14.18M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $13.41M 10-Q · filed 2013-04-24 |
| 2012-12-31 | $13.14M 10-K · filed 2016-03-03 |
| 2012-09-30 | $46.33M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $46.17M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $45.30M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $44.39M 10-K · filed 2015-02-18 |
| 2011-09-30 | $43.49M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $43.03M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $32.93M 10-K · filed 2014-02-05 |
| 2009-12-31 | $108.25M 10-K · filed 2013-02-08 |
| 2008-12-31 | $104.29M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |